StonvexLoading…
StonvexStonvexStonvexCore line items from CCBG's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q3 2026 (Est.) Expected 2026-07-20 | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|---|
Revenue | $65.53M | $51.02M | $204.39M | $152.67M | $101.24M |
Operating Income | Not available | $20.66M | $81.72M | $63.12M | $42.02M |
Net Income | Not available | $15.82M | $61.56M | $47.85M | $31.90M |
EPS (Diluted) | $0.92 | $0.92 | $3.60 | $2.80 | $1.87 |
Total Assets | Not available | $4.45B | $4.39B | $4.32B | $4.39B |
Total Liabilities | Not available | $3.89B | $3.83B | $3.78B | $3.87B |
Cash & Equivalents | Not available | $488.97M | $529.97M | $465.90M | $473.40M |
Free Cash Flow OCF − CapEx | Not available | $14.66M | $80.03M | $70.09M | $50.27M |
Shares Outstanding | Not available | 17.10M | 17.08M | 17.07M | 17.07M |